Ajanta Pharma Technical Analysis #60: Sell | Target Rs 900 | Arijit Banerjee

Sell Range970 – 950
Target900 – 890
Duration20 – 25 Trading Sessions
Potential Return^6 – 7%
CMP#IdeaSell RangeTargetStopLoss*DurationPotential Return^
960.3SELL970 – 950900 – 890102020 – 25 Trading Sessions6 – 7%

# CMP on June 14, 2019
* Maintain recommended StopLoss by daily closing basis.
   Once 1st target hit, reset StopLoss at 930.
^ The returns are calculated based on CMP#


Ajanta pharma, established in 1979, operating in Pharma & Healthcare sector, having 6 manufacturing units in India. This drug manufacturing company engaged in developing formulas, producing and marketing tablets, ointment, capsules and lotions. Most of its revenues generated from developing countries like Africa and India.

Stock Data
Sectoral IndexNifty Pharma
52W High1294
52W Low900.1
Face Value2
Relative Performance_Ajanta Pharma vs Nifty Pharma Index


  • The share price of Ajanta Pharma has been a declining trend since its lifetime high of ₹ 2125 registered during October 2016.
  • There is a steady resistance line which is moving downwards along with price fall. 
  • Presently, the stock price has placed near the Upper bound of a downward sloping channel and based on historical price pattern we are expecting the price to fall off from here.
Ajanta Pharma Weekly Chart
Ajanta Pharma Weekly Chart


  • In the daily chart, we are witnessing bearish MACD crossover.
  • The momentum oscillators are also suggesting a big downside in the stock. From the last few weeks, serious delivery selling was seen in the stock with negative price action which indicates a big downside soon.
Ajanta Pharma Daily Chart
Ajanta Pharma Daily Chart


Based on our best trading tips for short term, Ajanta Pharma share price target will be 900 – 890 in the next few days.


1)  It’s advisable not to enter/exit beyond the recommended range.
2)  Strictly follow the StopLoss as mentioned. Honour it.
3)  Use trailing StopLoss to retain profits.
4)  Diversify trading capital into our other technical recommendations.
5)  Risk only the money what you can afford to lose. Hedge accordingly.


The research analysis is prepared by Arijit Banerjee, CMT, CFTe. He is a veteran trader and an active investor having in-depth knowledge in financial market research, advanced technical analysis, market cycle, algorithmic trading and portfolio management. Arijit is a Chartered Market Technician (CMT) accredited by CMT Association USA, the leading global authority of Technical Analysis and has been honoured by Certified Financial Technician (CFTe) from the International Federation of Technical Analysts, USA. SEBI, the regulatory body of Indian financial market also recognizes him as a Research Analyst (INH300006582).


The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.

Enjoy this recommendation?
Share with your friends

Your return could be much more


access our premium recommendations

Swing Trading Advice

Subscription Period
3 months / 6 months / 12 months
7900 for 3 months*
  • * referred calendar months here
    e.g. Jan 20, 2020 — April 20, 2020

  • top 9-10 trade advice / month
  • average profit 9-10% / advice
  • short to medium term trade
  • ...and other exclusive benefits

Subscribe With Us

Get free Trading tips and Investment advice

We respect your privacy.

You cannot copy content of this page